Bing Liu
Eli Lilly (United States)
1 paper in the Anchorcite directory, published in 2022, cited 4,280 times in total.
ORCID profileResearch topics
- Diabetes Treatment and Management · 1 paper
- Pharmacology and Obesity Treatment · 1 paper
- Regulation of Appetite and Obesity · 1 paper
Frequent co-authors
- Ania M. Jastreboff · 1 paper
- Louis J. Aronne · 1 paper
- Nadia N. Ahmad · 1 paper
- Sean Wharton · 1 paper
- Lisa E. Connery · 1 paper
- Arihiro Kiyosue · 1 paper
- Shuyu Zhang · 1 paper
- Mathijs C. M. Bunck · 1 paper
Papers
- Tirzepatide Once Weekly for the Treatment of ObesityNew England Journal of Medicine · 2022 · 4,280 citations
BACKGROUND: Obesity is a chronic disease that results in substantial global morbidity and mortality. The efficacy and safety of tirzepatide, a novel glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist, in people with obesity are not known. METHODS: In this…
Metadata from OpenAlex (CC0).